June 2012 Briefing - OphthalmologyLast Updated: July 02, 2012.
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for June 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Apolipoproteins Are Biomarkers for Diabetic Retinopathy
FRIDAY, June 29 (HealthDay News) -- In patients with diabetes, with or without diabetic retinopathy, serum apolipoproteins (apos) are associated with markers of systemic and retinal microvascular dysfunction, according to a study published in the July issue of Diabetes.
Supreme Court Upholds Health Care Reform Law
THURSDAY, June 28 (HealthDay News) -- The U.S. Supreme Court voted June 28 to uphold the constitutionality of the Patient Protection and Affordable Care Act (PPACA), which has been the subject of debate and multiple lawsuits since its 2010 inception.
Duplicate Payments by Federal Government Increasing
WEDNESDAY, June 27 (HealthDay News) -- The federal government spends a substantial and increasing amount on individuals who are dually enrolled in separate managed care programs (the Veterans Affairs health care system [VA] and Medicare Advantage plan [MA]), according to a study published online June 26 in the Journal of the American Medical Association to coincide with presentation at the Annual Research Meeting of AcademyHealth, held from June 24 to 26 in Orlando, Fla.
Use of Electronic Records Tied to Fewer Malpractice Claims
TUESDAY, June 26 (HealthDay News) -- Use of electronic health records (EHRs) is associated with fewer medical malpractice claims among physicians from multiple surgical and medical specialties, according to a research letter published online June 25 in the Archives of Internal Medicine.
Glaucoma Stent Approved
MONDAY, June 25 (HealthDay News) -- An ocular stent that's designed to reduce inner-eye pressure among people with mild or moderate open-angle glaucoma has been approved by the U.S. Food and Drug Administration.
Half of Residents Report Working While Sick
THURSDAY, June 21 (HealthDay News) -- About half of residents have worked while sick, with many reporting feeling obligated to colleagues and patients, according to a research letter published online June 18 in the Archives of Internal Medicine.
Simple, Noninvasive Eye Test May Identify Risk for Stroke
FRIDAY, June 15 (HealthDay News) -- An eye test measuring ocular pulse amplitude (OPA) can be performed by ophthalmologists to detect severe carotid artery stenosis (CAS), a known risk factor for stroke, according to a study published in the June issue of Ophthalmology.
Corneal Cell Transplant Can Restore Corneal Transparency
FRIDAY, June 15 (HealthDay News) -- When given together with the selective Rho-associated kinase (ROCK) inhibitor Y-27632, transplanted corneal endothelial cells (CECs) can effectively treat damaged corneas in both rabbits and monkeys, according to an experimental study published online June 13 in The American Journal of Pathology.
Study Participation Ups Adherence for Glaucoma Patients
WEDNESDAY, June 13 (HealthDay News) -- For non-adherent patients with glaucoma, adherence measures are significantly improved for those assigned to an interactive, telephone-based communication intervention or usual care, according to a study published online June 11 in the Archives of Ophthalmology.
Cerebral Damage Key Risk for Visual Impairment in Preemies
WEDNESDAY, June 13 (HealthDay News) -- Cerebral damage and retinopathy of prematurity (ROP) are both independent risk factors for visual impairment in preschool children who were born extremely premature, with cerebral damage being the primary risk factor, according to a study published online June 11 in the Archives of Ophthalmology.
Gender Gap Exists in Physician Researchers' Salaries
TUESDAY, June 12 (HealthDay News) -- A survey of mid-career academic physician researchers shows that gender differences in salary exist even after adjusting for differences in specialty, institutional characteristics, academic productivity, academic rank, and work hours, according to a study published in the June 13 issue of the Journal of the American Medical Association.
Thiazolidinedione Use Linked to Diabetic Macular Edema
MONDAY, June 11 (HealthDay News) -- Treatment with a thiazolidinedione is associated with an increased one- and 10-year risk of diabetic macular edema (DME) in patients with type 2 diabetes, according to a study published online June 11 in the Archives of Internal Medicine.
|Previous: June 2012 Briefing - Hematology & Oncology||Next: June 2012 Briefing - Orthopedics|
Reader comments on this article are listed below. Review our comments policy.